Підписатись
Курята Олександр Вікторович | Kuryata Olexandr | Курята Александр Викторович
Курята Олександр Вікторович | Kuryata Olexandr | Курята Александр Викторович
Дніпровський державний медичний університет
Підтверджена електронна адреса в dsma.dp.ua - Домашня сторінка
Назва
Посилання
Посилання
Рік
Dabigatran versus warfarin in patients with atrial fibrillation
SJ Connolly, MD Ezekowitz, S Yusuf, J Eikelboom, J Oldgren, A Parekh, ...
New England journal of medicine 361 (12), 1139-1151, 2009
136272009
Eplerenone in patients with systolic heart failure and mild symptoms
F Zannad, JJV McMurray, H Krum, DJ van Veldhuisen, K Swedberg, H Shi, ...
New England Journal of Medicine 364 (1), 11-21, 2011
35742011
Apixaban in patients with atrial fibrillation
SJ Connolly, J Eikelboom, C Joyner, HC Diener, R Hart, S Golitsyn, ...
New England Journal of Medicine 364 (9), 806-817, 2011
32612011
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
K Swedberg, M Komajda, M Böhm, JS Borer, I Ford, A Dubost-Brama, ...
The Lancet 376 (9744), 875-885, 2010
32322010
Cholesterol lowering in intermediate-risk persons without cardiovascular disease
S Yusuf, J Bosch, G Dagenais, J Zhu, D Xavier, L Liu, P Pais, ...
New England Journal of Medicine 374 (21), 2021-2031, 2016
9592016
Tiotropium versus salmeterol for the prevention of exacerbations of COPD
C Vogelmeier, B Hederer, T Glaab, H Schmidt, MPMH Rutten-van Mölken, ...
New England Journal of Medicine 364 (12), 1093-1103, 2011
9522011
Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis
SE Nissen, ND Yeomans, DH Solomon, TF Lüscher, P Libby, ME Husni, ...
New England Journal of Medicine 375, 2519-2529, 2016
8392016
Blood-pressure lowering in intermediate-risk persons without cardiovascular disease
EM Lonn, J Bosch, P López-Jaramillo, J Zhu, L Liu, P Pais, R Diaz, ...
New England Journal of Medicine 374 (21), 2009-2020, 2016
7732016
Ivabradine in stable coronary artery disease without clinical heart failure
K Fox, I Ford, PG Steg, JC Tardif, M Tendera, R Ferrari
New England Journal of Medicine 371 (12), 1091-1099, 2014
6002014
Blood-pressure and cholesterol lowering in persons without cardiovascular disease
S Yusuf, E Lonn, P Pais, J Bosch, P Lopez-Jaramillo, J Zhu, D Xavier, ...
New England Journal of Medicine 374 (21), 2032-2043, 2016
4542016
Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial
HC Diener, J Eikelboom, SJ Connolly, CD Joyner, RG Hart, GYH Lip, ...
The Lancet Neurology 11 (3), 225-231, 2012
2252012
Bempedoic acid and cardiovascular outcomes in statin-intolerant patients
SE Nissen, AM Lincoff, D Brennan, KK Ray, D Mason, JJP Kastelein, ...
New England Journal of Medicine 388 (15), 1353-1364, 2023
2012023
Saxagliptin improves glycaemic control and is well tolerated in patients with type 2 diabetes mellitus and renal impairment
M Nowicki, I Rychlik, H Haller, ML Warren, L Suchower, I Gause‐Nilsson, ...
Diabetes, Obesity and Metabolism 13 (6), 523-532, 2011
1732011
European Guideline on IgG4-related digestive disease–UEG and SGF evidence-based recommendations
JM Löhr, U Beuers, M Vujasinovic, D Alvaro, JB Frøkjær, F Buttgereit, ...
United European gastroenterology journal 8 (6), 637-666, 2020
1342020
A dose-dependent improvement in exercise tolerance in patients with stable angina treated with mildronate: a clinical trial “MILSS I”
V Dzerve, mIlSS I Study group
Medicina 47 (10), 78, 2011
1102011
Effects of blood pressure and lipid lowering on cognition: Results from the HOPE-3 study
J Bosch, M O'Donnell, B Swaminathan, EM Lonn, M Sharma, G Dagenais, ...
Neurology 92 (13), e1435-e1446, 2019
642019
Prospective multicenter study of HX575 (biosimilar epoetin-α) in patients with chronic kidney disease applying a target hemoglobin of 10--12 g/dl.
WH Hörl, F Locatelli, M Haag-Weber, M Ode, K Roth
Clinical nephrology 78 (1), 24-32, 2012
442012
Эндотелиальная дисфункция при сердечной недостаточности с сохраненной систолической функцией и ее коррекция препаратом метаболического ряда милдронатом
ВП Гейченко, АВ Курята, ОВ Мужчиль
Российский кардиологический журнал, 68-71, 2005
312005
Возможности использования метаболического корректора милдроната в комплексном лечении хронической сердечной недостаточности с сохраненной систолической функцией
ВП Гейченко, АВ Курята, ОВ Мужчиль
Медицина неотложных состояний 8 (1), 73-78, 2007
252007
Effects of the lercanidipine–enalapril combination vs. the corresponding monotherapies on home blood pressure in hypertension: evidence from a large database
G Mancia, S Omboni, I Chazova, A Coca, X Girerd, H Haller, G Parati, ...
Journal of hypertension 34 (1), 139-148, 2016
212016
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–20